#drug discovery — Thursday, October 01, 2026 (2 items)
| 0 | ℹ |
Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer.
(pnas.org)
|
PNAS 2026-10-01 | #cancer #inhibitor #drug discovery #transcriptomics #selectivity | |
| 0 | ℹ |
GCF-anchored and target-oriented mining of metagenomic BGC space for bioactive product discovery.
(journals.asm.org)
|
Microbiology Spectrum 2026-10-01 | #metagenomics #biosynthesis #drug discovery #natural products #cytotoxicity |